Loading clinical trials...
Loading clinical trials...
Pancreatic adenocarcinoma (PAAD) patients following surgeries are prone to relapse shortly, while it is not well understood by current biomarkers. Given the potential associations of human leukocyte a...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
BAIYONG SHEN
Collaborators
NCT06388967 · Pancreatic Cancer, Pancreatic Carcinoma, and more
NCT06496373 · Pancreatic Cancer Resectable, Chemotherapy-intolerant
NCT07157605 · Pancreatic Cancer Resectable, Pancreatectomy
NCT07081360 · Pancreas Cancer, Periampullary Cancer, and more
NCT06368063 · Pancreatic Cancer Resectable
Ruijin Hospital
Shanghai, Shanghai Municipality
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions